Triethylamine → (3-(4-(2-Oxa-7-azaspiro[4.4]nonan-7-ylmethyl)-3-methylphenoxy)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone
反応式
Cl.[CH2:2]1[C:6]2([CH2:10][CH2:9][NH:8][CH2:7]2)[CH2:5][CH2:4][O:3]1.C(N(CC)CC)C.[CH3:18][C:19]1[CH:26]=[C:25]([O:27][CH:28]2[CH2:31][N:30]([C:32]([C:34]3[O:35][C:36]([C:39]4[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=4)=[N:37][N:38]=3)=[O:33])[CH2:29]2)[CH:24]=[CH:23][C:20]=1[CH:21]=O.[Na].C([O-])(O)=O.[Na+]>ClCCl>[CH2:2]1[C:6]2([CH2:10][CH2:9][N:8]([CH2:21][C:20]3[CH:23]=[CH:24][C:25]([O:27][CH:28]4[CH2:31][N:30]([C:32]([C:34]5[O:35][C:36]([C:39]6[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=6)=[N:37][N:38]=5)=[O:33])[CH2:29]4)=[CH:26][C:19]=3[CH3:18])[CH2:7]2)[CH2:5][CH2:4][O:3]1参加物
7
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
2-Oxa-7-azaspiro[4.4]nonane HCl salt (0.07 g, 0.43 mmol) was dissolved in dichloromethane (2 ml). Triethylamine (0.064 ml, 0.47 mmol) was added, followed by 2-methyl-4-(1-(5-phenyl-1,3,4-oxadiazole-2-carbonyl)azetidin-3-yloxy)benzaldehyde (0.13 g, 0.36 mmol) and sodium triacetoxyhydroborate (0.152 g, 0.72 mmol). The resulting mixture was stirred at ambient temperature overnight. The reaction mixture was diluted with dichloromethane (10 ml) and then shaken with NaHCO3 (sat. 3 ml). The two phases were separated by the use of a phase separator. Evaporation of the organic phase afforded crude material, which was purified by preparative reverse-phase HPLC at pH 10 to give 85 mg (50%) of the desired product as a solid.
後処理
- customThe two phases were separated by the use of a phase separator
- customEvaporation of the organic phase
- customafforded crude material, which
- customwas purified by preparative reverse-phase HPLC at pH 10
出典と根拠
- ORDレコード
- ord-eec88a2a85714eb6928298d4cc038a7b
- 出典データセット
- uspto-grants-2014_04
- 特許番号
- US08685958B2
反応ノート
読み込み中…